Stock & Company Details
Novo-Nordisk A/S $NVO
Price:
N/A
N/A
3.4B
$169B
52 Week High:
N/A
10 Day Average Volume:
N/A
1.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
NVO technical indicators
Latest Novo-Nordisk A/S (NVO) indicator readings as of 2026-10-09.
NVO's 14-day RSI is 37.9, in neutral territory. At $38.64 it is trading 14.9% below its 200-day moving average of $45.40, and below its 50-day average of $43.43. Price sits in the middle of its Bollinger Bands ($35.29 to $43.58). ADX reads 35.0, indicating a trending market.
NVO backtested strategy results
How 4 rule-based strategies performed on Novo-Nordisk A/S (NVO) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +24.2% | 45% | 11 | -43.6% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +17.4% | 29% | 31 | -38.5% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +21.1% | 45% | 29 | -31.2% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +3.2% | 67% | 21 | -38.3% |
Overview
Novo Nordisk (NVO) is a global healthcare leader focused on diabetes care, obesity treatments, and rare disease therapies. Headquartered in Denmark, the company develops innovative GLP-1 and insulin products that serve millions of patients worldwide. With strong growth driven by demand for weight-loss and metabolic treatments, NVO combines consistent revenue expansion, high margins, and significant investment in research and development.
Finance Bot
Ask your questions
Start by typing a question below.
